Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.

Smith C, Moraka NO, Ibrahim M, Moyo S, Mayondi G, Kammerer B, Leidner J, Gaseitsiwe S, Li S, Shapiro R, Lockman S, Weinberg A.

J Infect Dis. 2019 Nov 10. pii: jiz590. doi: 10.1093/infdis/jiz590. [Epub ahead of print]

PMID:
31711179
2.

Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.

Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, Chakalisa U, Bennett K, Leidner J, Manyake K, Mbikiwa AM, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Lebelonyane R, Alwano MG, Powis KM, Dryden-Peterson SL, Kgathi C, Novitsky V, Moore J, Bachanas P, Abrams W, Block L, El-Halabi S, Marukutira T, Mills LA, Sexton C, Raizes E, Gaseitsiwe S, Bussmann H, Okui L, John O, Shapiro RL, Pals S, Michael H, Roland M, DeGruttola V, Lei Q, Wang R, Tchetgen Tchetgen E, Essex M, Lockman S.

N Engl J Med. 2019 Jul 18;381(3):230-242. doi: 10.1056/NEJMoa1812281.

PMID:
31314967
3.

In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana.

Cassidy AR, Williams PL, Leidner J, Mayondi G, Ajibola G, Makhema J, Holding PA, Powis KM, Batlang O, Petlo C, Shapiro R, Kammerer B, Lockman S.

Pediatr Infect Dis J. 2019 Aug;38(8):828-834. doi: 10.1097/INF.0000000000002332.

PMID:
30985518
4.

Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.

Moraka NO, Moyo S, Mayondi G, Leidner J, Ibrahim M, Smith C, Weinberg A, Li S, Thami PK, Kammerer B, Ajibola G, Musonda R, Shapiro R, Gaseitsiwe S, Lockman S.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):118-124. doi: 10.1097/QAI.0000000000001982.

PMID:
30964806
5.

Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.

Moyo S, Gaseitsiwe S, Mohammed T, Pretorius Holme M, Wang R, Kotokwe KP, Boleo C, Mupfumi L, Yankinda EK, Chakalisa U, van Widenfelt E, Gaolathe T, Mmalane MO, Dryden-Peterson S, Mine M, Lebelonyane R, Bennett K, Leidner J, Wirth KE, Tchetgen Tchetgen E, Powis K, Moore J, Clarke WA, Lockman S, Makhema JM, Essex M, Novitsky V.

PLoS One. 2018 Oct 24;13(10):e0204840. doi: 10.1371/journal.pone.0204840. eCollection 2018.

6.

HIV Exposure and Formula Feeding Predict Under-2 Mortality in HIV-Uninfected Children, Botswana.

Ajibola G, Leidner J, Mayondi GK, van Widenfelt E, Madidimalo T, Petlo C, Moyo S, Mmalane M, Williams PL, Cassidy AR, Shapiro R, Kammerer B, Lockman S.

J Pediatr. 2018 Dec;203:68-75.e2. doi: 10.1016/j.jpeds.2018.08.009. Epub 2018 Oct 11.

7.

Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana.

Kacanek D, Williams PL, Mayondi G, Holding P, Leidner J, Moabi K, Tepper V, Nichols S, Makhema J, Jibril H, Madidimalo T, Shapiro R, Lockman S, Kammerer B.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):e93-e100. doi: 10.1097/QAI.0000000000001799.

8.

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.

Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, Lockman S, Gaseitsiwe S.

Genes (Basel). 2018 May 17;9(5). pii: E259. doi: 10.3390/genes9050259.

9.

Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana.

Powis KM, Lockman S, Ajibola G, Hughes MD, Bennett K, Leidner J, Batlang O, Botebele K, Moyo S, van Widenfelt E, Makhema J, Petlo C, Jibril HB, McIntosh K, Essex M, Shapiro RL.

South Afr J HIV Med. 2018 Mar 28;19(1):751. doi: 10.4102/sajhivmed.v19i1.751. eCollection 2018.

10.

In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.

Chaudhury S, Mayondi GK, Williams PL, Leidner J, Shapiro R, Diseko M, Ajibola G, Holding P, Tepper V, Makhema J, Petlo C, Seage GR 3rd, Lockman S, Kammerer B.

AIDS. 2018 Jun 1;32(9):1173-1183. doi: 10.1097/QAD.0000000000001790.

11.

Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana.

Powis KM, Souda S, Lockman S, Ajibola G, Bennett K, Leidner J, Hughes MD, Moyo S, van Widenfelt E, Jibril HB, Makhema J, Essex M, Shapiro RL.

J Int AIDS Soc. 2017 Nov;20(3). doi: 10.1002/jia2.25021.

12.

Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.

Chaudhury S, Williams PL, Mayondi GK, Leidner J, Holding P, Tepper V, Nichols S, Magetse J, Sakoi M, Moabi K, Makhema J, Mdluli C, Jibril H, Seage GR 3rd, Kammerer B, Lockman S.

Pediatrics. 2017 Oct;140(4). pii: e20170988. doi: 10.1542/peds.2017-0988. Epub 2017 Sep 14.

13.

Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.

Lockman S, Hughes M, Powis K, Ajibola G, Bennett K, Moyo S, van Widenfelt E, Leidner J, McIntosh K, Mazhani L, Makhema J, Essex M, Shapiro R.

Lancet Glob Health. 2017 May;5(5):e491-e500. doi: 10.1016/S2214-109X(17)30143-2.

14.

High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy.

Zash RM, Souda S, Leidner J, Binda K, Hick C, Powis K, Makhema J, Mmalane M, Essex M, Lockman S, Shapiro RL.

AIDS Patient Care STDS. 2017 Jan;31(1):14-19. doi: 10.1089/apc.2016.0154.

15.

The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding.

Zash RM, Shapiro RL, Leidner J, Wester C, McAdam AJ, Hodinka RL, Thior I, Moffat C, Makhema J, McIntosh K, Essex M, Lockman S.

Paediatr Int Child Health. 2016 Aug;36(3):189-97. doi: 10.1179/2046905515Y.0000000038.

16.

HIV-exposed children account for more than half of 24-month mortality in Botswana.

Zash R, Souda S, Leidner J, Ribaudo H, Binda K, Moyo S, Powis KM, Petlo C, Mmalane M, Makhema J, Essex M, Lockman S, Shapiro R.

BMC Pediatr. 2016 Jul 21;16:103. doi: 10.1186/s12887-016-0635-5.

17.

Predictors of early breastfeeding cessation among HIV-infected women in Botswana.

Ogwu A, Moyo S, Powis K, Asmelash A, Lockman S, Moffat C, Leidner J, Makhema J, Essex M, Shapiro R.

Trop Med Int Health. 2016 Aug;21(8):1013-1018. doi: 10.1111/tmi.12729. Epub 2016 Jun 16.

18.

Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional study.

Mayondi GK, Wirth K, Morroni C, Moyo S, Ajibola G, Diseko M, Sakoi M, Magetse JD, Moabi K, Leidner J, Makhema J, Kammerer B, Lockman S.

BMC Public Health. 2016 Jan 16;16:44. doi: 10.1186/s12889-015-2498-3.

19.

No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.

Souda S, Gaseitsiwe S, Georgette N, Powis K, Moremedi D, Iketleng T, Leidner J, Moffat C, Ogwu A, Lockman S, Moyo S, Mmalane M, Musonda R, Makhema J, Essex M, Shapiro R.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):572-7. doi: 10.1097/QAI.0b013e31829308f8.

20.

Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.

Shapiro RL, Rossi S, Ogwu A, Moss M, Leidner J, Moffat C, Lockman S, Moyo S, Makhema J, Essex M, Capparelli E.

Antivir Ther. 2013;18(4):585-90. doi: 10.3851/IMP2474. Epub 2012 Nov 26.

Supplemental Content

Loading ...
Support Center